Relmada Therapeutics (NASDAQ:RLMD) stock revealed change of 735.22% away from 52-week low price and recently located move of -19.96% off 52-week high price. It has market worth of $555.17M. RLMD stock has been recorded 13.80% away from 50 day moving average and 142.06% away from 200 day moving average. Moving closer, we can see that shares have been trading -1.87% off 20-day moving average.
On Jan. 10, 2020, Relmada Therapeutics (NASDAQ:RLMD) a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, disclosed that Maged Shenouda has been appointed the Company’s new Chief Financial Officer (CFO). Mr. Shenouda, who has nearly 30 years of biotechnology and equity research experience, has also stepped down from the Company’s Board of Directors in order to join the executive management team. Relmada’s current CFO, Charles Ence, will assume a new role in the expanded financial team as the Company’s Chief Accounting and Compliance Officer.
We are thrilled that Maged has agreed to join Relmada’s senior executive management team as Chief Financial Officer, said Sergio Traversa, Chief Executive Officer of Relmada. He is an accomplished financial executive in the biotechnology industry, in addition to his significant industry-related experience as an equity research analyst on Wall Street. Maged’s substantial financial expertise and deep understanding of the drug development landscape will be critical to Relmada as we continue to develop our lead product candidate, REL-1017 (dextromethadone), as an adjunctive treatment in patients with major depression. We are also extremely pleased that Chuck Ence will continue with Relmada in the key role of Chief Accounting and Compliance Officer in an expanded financial team. With Maged and Chuck together, we believe that we have extremely solid financial operations in place.
The Healthcare sector company, Relmada Therapeutics noticed change of -0.05% to $38.42 along volume of 176639 shares in recent session compared to an average volume of 206.17K shares. The stock observed return of -0.13% in 5 days trading activity. The stock was at -3.83% over one month performance. RLMD’s shares are at 250.59% for the quarter and driving a 693.80% return over the course of the past year and is now at -1.49% since this point in 2018.
The average volatility for the week at 3.64% and for month was at 6.30%. There are 14.45M shares outstanding and 12.68M shares are floated in market. Right now the stock beta is -0.01.